Abstract
Background
Women are under-represented in many key studies and trials examining outcomes of catheter ablation (CA) for ventricular arrhythmias (VA). We compared characteristics between men and women undergoing their first catheter ablation for VA at a single centre over 10 years.
Methods
The clinical, procedural characteristics and outcomes of 287 consecutive patients (male = 182, female = 105), undergoing their first CA at our centre over 10 years were compared according to sex and underlying heart disease.
Results
In the ablation population, women were younger, had fewer co-morbidities, were less likely to have ischemic cardiomyopathy (ICM) and VA storm and were more likely to have idiopathic VA and premature ventricular complexes as the indication for ablation (P < 0.05 for all). Amongst idiopathic and non-ischemic cardiomyopathy (NICM) subgroups, baseline characteristics were similar; amongst ICM, women were younger and had higher numbers of drug failure pre-ablation (P = 0.05). Women were similar to men in all procedural characteristics, acute procedural success and complications, regardless of underlying heart disease. At median follow-up of 666 days, VA-free survival, overall mortality and survival free of death or transplant were comparable in both groups. Sex was not a predictor of these outcomes, after accounting for clinical and procedural characteristics.
Conclusion
Women represented 36% of the real-world population at our centre referred for CA of VA. There are key differences in clinical features of women versus men referred for VA ablation. Despite these differences, VA ablation in women can be accomplished with similar success and complication rates to men, regardless of underlying heart disease.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Abbreviations
- AAD:
-
Anti-arrhythmic drug
- ATP:
-
Anti-tachycardia pacing
- CA:
-
Catheter ablation
- CF:
-
Contact force
- CI:
-
Confidence interval
- EAM:
-
Electroanatomic mapping
- ECG:
-
Electrocardiogram
- EPS:
-
Electrophysiology study
- HR:
-
Hazard ratio
- Hz:
-
Hertz
- ICD:
-
Implantable cardioverter defibrillator
- ICE:
-
Intracardiac echocardiography
- ICM:
-
Ischemic cardiomyopathy
- IQR:
-
Interquartile range
- LV:
-
Left ventricle
- LVEF:
-
Left ventricle ejection fraction
- mA:
-
Milliamps
- ms:
-
Milliseconds
- NICM:
-
Non-ischemic cardiomyopathy
- PES:
-
Programmed electrical stimulation
- PVC:
-
Premature ventricular complex
- RMN:
-
Remote magnetic navigation
- RV:
-
Right ventricle
- SD:
-
Standard deviation
- SHD:
-
Structural heart disease
- VA:
-
Ventricular arrhythmia
- VT:
-
Ventricular tachycardia
References
Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657–65. https://doi.org/10.1056/NEJMoa065457.
Kuck K-H, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner H-F, Kautzner J, Schumacher B, Hansen PS. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. The Lancet. 2010;375(9708):31–40. https://doi.org/10.1016/S0140-6736(09)61755-4.
Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111–21. https://doi.org/10.1056/NEJMoa1513614.
Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, Zarse M, Hohnloser SH, Kautzner J, Willems S, Investigators SMS. Impact of Substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study). Circulation: Arrhythmia and Electrophysiology. 2017;10 (3). https://doi.org/10.1161/CIRCEP.116.004422
Berger JS, Elliott L, Gallup D, Roe M, Granger CB, Armstrong PW, Simes RJ, White HD, Van de Werf F, Topol EJ, Hochman JS, Newby LK, Harrington RA, Califf RM, Becker RC, Douglas PS. Sex differences in mortality following acute coronary syndromes. JAMA. 2009;302(8):874–82. https://doi.org/10.1001/jama.2009.1227.
Gillis AM. Atrial fibrillation and ventricular arrhythmias. Circulation. 2017;135(6):593–608. https://doi.org/10.1161/CIRCULATIONAHA.116.025312.
Liao JN, Hu YF, Lin WS, Lin YJ, Chang SL, Lo LW, Duan TC, Chung FP, Li CH, Chao TF, Hartono B, Chen SA. Gender difference in idiopathic right ventricular outflow tract-ventricular tachycardia. Acta Cardiologica Sinica. 2013;29(4):304–10.
Lin CY, Chung FP, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Chang YT, Chen YY, Walia R, Te ALD, Yamada S, Chen SA. Gender differences in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical manifestations, electrophysiological properties, substrate characteristics, and prognosis of radiofrequency catheter ablation. Int J Cardiol. 2017;227:930–7. https://doi.org/10.1016/j.ijcard.2016.11.055.
Baldinger SH, Kumar S, Romero J, Fujii A, Epstein LM, Michaud GF, John R, Tedrow UB, Stevenson WG. A comparison of women and men undergoing catheter ablation for sustained monomorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2017;28(2):201–7. https://doi.org/10.1111/jce.13127.
Frankel DS, Tung R, Santangeli P, Tzou WS, Vaseghi M, Di Biase L, Nagashima K, Tedrow U, Bunch TJ, Tholakanahalli VN, Dendi R, Reddy M, Lakkireddy D, Dickfeld T, Weiss JP, Mathuria N, Vergara P, Patel M, Nakahara S, Vakil K, Sauer WH, Callans DJ, Natale A, Stevenson WG, Della Bella P, Shivkumar K, Marchlinski FE. Sex and catheter ablation for ventricular tachycardia: an international ventricular tachycardia ablation center collaborative group study. JAMA cardiology. 2016;1(8):938–44. https://doi.org/10.1001/jamacardio.2016.2361.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–6. https://doi.org/10.1093/eurheartj/ehm342.
Campbell T, Trivic I, Bennett RG, Anderson RD, Turnbull S, Pham T, Nalliah C, Kizana E, Watts T, Lee G, Kumar S. Catheter ablation of ventricular arrhythmia guided by a high-density grid catheter. J Cardiovasc Electrophysiol. 2020;31(2):474–84. https://doi.org/10.1111/jce.14351.
Anderson RD, Lee G, Trivic I, Campbell T, Pham T, Nalliah C, Kizana E, Thomas SP, Trivedi SJ, Watts T, Kalman J, Kumar S. Focal ventricular tachycardias in structural heart disease: prevalence, characteristics, and clinical outcomes after catheter ablation. JACC Clin Electrophysiol. 2020;6(1):56–69. https://doi.org/10.1016/j.jacep.2019.09.013.
Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101(11):1288–96. https://doi.org/10.1161/01.cir.101.11.1288.
Hutchinson MD, Gerstenfeld EP, Desjardins B, Bala R, Riley MP, Garcia FC, Dixit S, Lin D, Tzou WS, Cooper JM, Verdino RJ, Callans DJ, Marchlinski FE. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(1):49–55. https://doi.org/10.1161/CIRCEP.110.959957.
Polin GM, Haqqani H, Tzou W, Hutchinson MD, Garcia FC, Callans DJ, Zado ES, Marchlinski FE. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2011;8(1):76–83. https://doi.org/10.1016/j.hrthm.2010.09.088.
Soejima K, Stevenson WG, Maisel WH, Sapp JL, Epstein LM. Electrically unexcitable scar mapping based on pacing threshold for identification of the reentry circuit isthmus: feasibility for guiding ventricular tachycardia ablation. Circulation. 2002;106(13):1678–83. https://doi.org/10.1161/01.cir.0000030187.39852.a7.
Borger Van Der Burg AE, De Groot NMS, Van Erven L, Bootsma M, Van Der Wall EE, Schalij MJ. Long-term follow-up after radiofrequency catheter ablation of ventricular tachycardia: a successful approach? J Cardiovasc Electrophysiol. 2002;13(5):417–23.
Schweikert RA, Saliba WI, Tomassoni G, Marrouche NF, Cole CR, Dresing TJ, Tchou PJ, Bash D, Beheiry S, Lam C, Kanagaratnam L, Natale A. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation. 2003;108(11):1329–35.
Sacher F, Tedrow UB, Field ME, Raymond JM, Koplan BA, Epstein LM, Stevenson WG. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol. 2008;1(3):153–61. https://doi.org/10.1161/circep.108.769471.
Di Biase L, Santangeli P, Astudillo V, Conti S, Mohanty P, Mohanty S, Sanchez JE, Horton R, Thomas B, Burkhardt JD, Natale A. Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the remote magnetic navigation system and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case-control series. Heart Rhythm. 2010;7(8):1029–35. https://doi.org/10.1016/j.hrthm.2010.04.036.
Tung R, Michowitz Y, Yu R, Mathuria N, Vaseghi M, Buch E, Bradfield J, Fujimura O, Gima J, Discepolo W, Mandapati R, Shivkumar K. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Heart Rhythm. 2013;10(4):490–8. https://doi.org/10.1016/j.hrthm.2012.12.013.
Kumar S, Romero J, Mehta NK, Fujii A, Kapur S, Baldinger SH, Barbhaiya CR, Koplan BA, John RM, Epstein LM, Michaud GF, Tedrow UB, Stevenson WG. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm. 2016;13(10):1957–63. https://doi.org/10.1016/j.hrthm.2016.07.001.
Romero J, Stevenson WG, Fujii A, Kapur S, Baldinger SH, Mehta NK, John RM, Michaud GF, Epstein LM, Koplan BA, Tedrow UB, Kumar S. Impact of number of oral antiarrhythmic drug failures before referral on outcomes following catheter ablation of ventricular tachycardia. JACC Clin Electrophysiol. 2018;4(6):810–9. https://doi.org/10.1016/j.jacep.2018.01.016.
Bella PD, Brugada J, Zeppenfeld K, Merino J, Neuzil P, Maury P, Maccabelli G, Vergara P, Baratto F, Berruezo A, Wijnmaalen AP. Epicardial ablation for ventricular tachycardia. Circulation arrhythmia and electrophysiology. 2011;4(5):653–9. https://doi.org/10.1161/CIRCEP.111.962217.
Kentner AC, Grace SL. Between mind and heart: sex-based cognitive bias in cardiovascular disease treatment. Front Neuroendocrinol. 2017;45:18–24. https://doi.org/10.1016/j.yfrne.2017.02.002.
Bell JR, Bernasochi GB, Varma U, Raaijmakers AJA, Delbridge LMD. Sex and sex hormones in cardiac stress—mechanistic insights. J Steroid Biochem Mol Biol. 2013;137:124–35. https://doi.org/10.1016/j.jsbmb.2013.05.015.
Kander MC, Cui Y, Liu Z. Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med. 2017;21(5):1024–32. https://doi.org/10.1111/jcmm.13038.
Tadros R, Ton A-T, Fiset C, Nattel S. Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms. Can J Cardiol. 2014;30(7):783–92. https://doi.org/10.1016/j.cjca.2014.03.032.
Schulze-Bahr E, Kirchhof P, Eckardt L, Bertrand J, Breithardt G. Gender differences in cardiac arrhythmias. Herz. 2005;30(5):390–400. https://doi.org/10.1007/s00059-005-2724-3.
Zaman S, Deshmukh T, Aslam A, Martin C, Kovoor P. Sex differences in electrophysiology ventricular tachyarrhythmia cardiac arrest and sudden cardiac death following acute myocardial infarction. Heart lung and circulation. 2019. https://doi.org/10.1016/j.hlc.2019.07.017.
Kuo L, Shirai Y, Muser D, Liang JJ, Castro SA, Santangeli P, Schaller RD, Supple GE, Lin D, Nazarian S, Dixit S, Callans DJ, Marchlinski FE, Frankel DS. Comparison of the arrhythmogenic substrate between men and women with nonischemic cardiomyopathy. Heart Rhythm. 2019;16(9):1414–20. https://doi.org/10.1016/j.hrthm.2019.03.024.
Ehdaie A, Cingolani E, Shehata M, Wang X, Curtis AB, Chugh SS. Sex differences in cardiac arrhythmias clinical and research implications. Circulation: arrhythmia and electrophysiology. 2018;11(3). https://doi.org/10.1161/CIRCEP.117.005680
Tompkins CM, Kutyifa V, Arshad A, McNitt S, Polonsky B, Wang PJ, Moss AJ, Zareba W. Sex differences in device therapies for ventricular arrhythmias or death in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT) Trial. J Cardiovasc Electrophysiol. 2015;26(8):862–71. https://doi.org/10.1111/jce.12701.
McLaughlin TJ, Jain SK, Voigt AH, Wang NC, Saba S. Comparison of long-term survival following sudden cardiac arrest in men versus women. Am J Cardiol. 2019;124(3):362–6. https://doi.org/10.1016/j.amjcard.2019.04.051.
Funding
Saurabh Kumar is supported by the NSW Health Early-Mid Career Fellowship.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Timmy Pham, Richard Bennett, Timothy Campbell, Samual Turnbull, Juliana Kanawati, Stuart P. Thomas and Saurabh Kumar. The first draft of the manuscript was written by Timmy Pham and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
The study was performed according to protocols approved by the Western Sydney Local Health District Human Research Ethics Committee and complies with the 1964 Declaration of Helsinki and its later amendments.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
Timothy Campbell has received speakers’ honoraria for Biosense Webster, Inc. in the last 12 months.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pham, T., Bennett, R., Kanawati, J. et al. Impact of sex on clinical, procedural characteristics and outcomes of catheter ablation for ventricular arrhythmias according to underlying heart disease. J Interv Card Electrophysiol 66, 203–213 (2023). https://doi.org/10.1007/s10840-022-01188-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-022-01188-y